Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
Clinical trial NCT00070083 · COMPLETED
Trial details
- NCT number
- NCT00070083
- Sponsor
- British Columbia Cancer Agency
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-07-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.